Frontiers in Veterinary Science published a paper by Dr. Alfred M. Legendre and colleagues
describing a field trial of Polyprenyl Immunostimulant (PI) in cats with non-effusive FIP.
We focus on theimmunitybecause it is the system that protects us and our pets against disease and allows us and our pets live happier, healthier lives.
Our company was formed to offer unique and specialty products that help strengthen immunity in our pets. And the first USDA approved product we are happy to offer is:
Polyprenyl Immunostimulant,the first and only therapeutic approved by USDA for signs associated with feline rhinotracheitis (herpes) virus infection.